UNITY Biotechnology Reports Granting of New Employment Inducement Awards
UNITY Biotechnology, Inc. (NASDAQ: UBX) announced the grant of stock-based awards totaling 190,000 shares from October 19 to November 2, 2021. This includes options for 160,000 shares and 30,000 restricted stock units, which will vest after one year. These grants were made under the amended 2020 Employment Inducement Incentive Plan to incentivize newly hired employees, as per Nasdaq Rule 5635(c)(4). UNITY is focused on developing therapeutics targeting age-related diseases by eliminating senescent cells.
- Grant of 190,000 shares enhances employee retention and attraction.
- Focus on developing therapeutics for age-related diseases shows innovative potential.
- None.
SOUTH SAN FRANCISCO, Calif., Nov. 03, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that from October 19, 2021, through November 2, 2021, the Compensation Committee of the Board of Directors (the “Board”) granted two new employees stock-based awards covering an aggregate of 190,000 shares of UNITY common stock, including options to purchase an aggregate of 160,000 shares of UNITY common stock and one grant consisting of 30,000 restricted stock units which will vest on the one-year anniversary of the vesting commencement date. The stock-based awards were granted pursuant to the UNITY 2020 Employment Inducement Incentive Plan, as amended, which was approved by the Board in March 2020 to provide for grants to newly hired employees as a material inducement for them to commence employment with UNITY in accordance with Nasdaq Stock Market Rule 5635(c)(4).
About UNITY
UNITY is developing a new class of therapeutics to slow, halt or reverse diseases of aging. UNITY’s current focus is on creating medicines to selectively eliminate or modulate senescent cells and thereby provide transformative benefit in age-related ophthalmologic and neurologic diseases. More information is available at www.unitybiotechnology.com or follow us on Twitter and LinkedIn.
Media
Canale Communications
Jason Spark
Jason.spark@canalecomm.com
FAQ
What stock-based awards did UNITY grant between October 19 and November 2, 2021?
What is the purpose of the stock-based awards granted by UNITY?
How does UNITY's 2020 Employment Inducement Incentive Plan work?
Which stock market rule is UNITY's grant of stock-based awards compliant with?
What is UNITY Biotechnology's primary focus?
